Compugen Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
CGEN
IL0010852080
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
801.6 ILa | -0.36% | +8.72% | +16.51% |
Mar. 08 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
Mar. 05 | Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024 |
Sales 2024 * | 37.9M 14.04B | Sales 2025 * | 35.29M 13.07B | Capitalization | 192M 71.31B |
---|---|---|---|---|---|
Net income 2024 * | -13M -4.82B | Net income 2025 * | -29M -10.74B | EV / Sales 2024 * | 5.08 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.45 x |
P/E ratio 2024 * |
-16.5
x | P/E ratio 2025 * |
-7.96
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.62% |
Latest transcript on Compugen Ltd.
1 day | -0.36% | ||
1 week | +8.72% | ||
Current month | +8.72% | ||
1 month | -9.33% | ||
3 months | +1.03% | ||
6 months | +189.28% | ||
Current year | +16.51% |
Managers | Title | Age | Since |
---|---|---|---|
Anat Cohen-Dayag
CEO | Chief Executive Officer | 57 | 01-12-31 |
Alberto Sessa
DFI | Director of Finance/CFO | 61 | 22-10-31 |
Eran Ophir
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 65 | 17-10-01 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 18-06-10 |
Gilead Halevy
BRD | Director/Board Member | 57 | 18-06-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 801.6 | -0.36% | 26 329 |
24-05-06 | 804.5 | +1.13% | 65,300 |
24-05-05 | 795.5 | +4.67% | 22,547 |
24-05-02 | 760 | +5.06% | 610,854 |
24-05-01 | 723.4 | -1.89% | 78,597 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 07, 2024 at 05:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.81% | 46.81B | |
+47.07% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |
- Stock Market
- Equities
- CGEN Stock
- CGEN Stock